Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs

North East
19 June 2013 12:49



Hertfordshire
19 June 2013 12:48



1x Oxford/London AND 1x North-West UK
19 June 2013 12:16


Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Joe Moore
Operations Director
joe@zenopa.com
+44 1494 818011

Testimonials
Thanks very much to the Zenopa team for all your help with finding me my great new position! You made my job search so easy by finding the vacancies, sending my CV.
Tom, 2011

New stem cell study reveals Parkinson's research insight

6 July 2012 16:10 in Scientific Developments/Breakthroughs


A new study into stem cell technology has revealed a potential new means of developing personalised therapies for Parkinson's disease.

The National Institutes of Health (NIH)-funded study involved the collection of skin cells from patients with genetically inherited forms of Parkinson's, before these cells were reprogrammed into neurons.

This resulted in the creation of neurons that showed common signs of distress and vulnerability, while also offering different responses to treatment based on the form of Parkinson's each patient had.

Using this technique, scientists can more easily investigate signs of the disease and test how different versions of the condition respond to new drug treatments.

Dr Margaret Sutherland, a programme director at NIH's National Institute of Neurological Disorders and Stroke, said: "These findings suggest new opportunities for clinical trials of Parkinson's disease, in which cell reprogramming technology could be used to identify the patients most likely to respond to a particular intervention."

Currently, around 127,000 people in the UK are affected by the debilitating condition.ADNFCR-8000103-ID-801402471-ADNFCR

Other news stories from 06/07/2012

Recent news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



             
© Copyright 2013 Zenopa Ltd